A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With ...
A Multicenter, Single Arm, Open-label Study to Investigate the Efficacy and Safety of Ravagalimab (ABBV-323) in Subjects With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy A Multicenter, Single Arm, Open-label Study to Investigate the Efficacy and Safety of Ravagalimab (A ...
Ulcerative Colitis (UC)
Drug: ABBV-323 Dose A;Drug: ABBV-323 Dose B
AbbVie
NULL
Completed
18 Years
75 Years
All
42
Phase 2
United States;Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom United States;Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdo ...